KeyStone’s Your Stock Our Take is BioSyent Inc. (RX:TSX-V), our Star is Zynex Inc. (ZYXI: NASDAQ) & our Dog is Lassonde Industries Inc. (LAS.A:TSX)
This week in our Your Stock, Our Take segment we look at BioSyent Inc. (RX:TSX-V), a Canadian specialty pharmaceutical company. Primary product is FeraMAX®, an over-the-counter iron supplement. A listener asks if it is time to take a look at this stock again in 2019? Our Star of the week is (should be no stranger to KeyStone Clients) - Zynex Inc. (ZYXI: NASDAQ), which manufactures and sells non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics. Primary offering electrotherapy medical devices used for pain management and rehabilitation. The stock has surged 82% year-to-date and roughly the same amount since our BUY recommendation just over a year ago. The company recently announced that it has graduated to the NASDAQ exchange and will be announcing its 2018 annual results and outlook next week. Finally, our Dog of the week is Lassonde Industries Inc. (LAS.A:TSX), a North American leader in the development, manufacture and sale of a wide range of ready-to-drink fruit and vegetable juices and drinks. The stock is down over 13% in the last couple days. Is it a Dog or an opportunity?
Be the first to find out the latest Keystone Financial news